c-Met inhibitor 1

• UNSPSC Description:

  c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer. IC50 value: Target: c-Met More details please refer to Patent WO 2012015677 A1.

• Target Antigen:

  c-Met/HGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/c-Met-inhibitor-1.html

• Solubility:

  DMSO : 20 mg/mL (ultrasonic)

• Smiles:

  CN1N=CC(C2=NN3C(C=C2)=NN=C3SC4=CC5=CN(C)N=C5C=C4)=C1

• Molecular Weight:

  362.41

• References & Citations:

  [1]PCT Int. Appl. (2012), WO 2012015677 A1 20120202.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1357072-61-7